In November 2018, Nutritional Medicinals, LLC (d.b.a. "Functional Formularies" or the “Company") announced a majority recapitalization transaction with Swander Pace Capital. 

Founded in 2006 by professional chef and nutrition expert Robin Gentry McGee, Functional Formularies is the leading provider of organic, whole food, shelf-stable feeding tube formulas. Ms. Gentry McGee created the Company after searching unsuccessfully for natural alternatives to traditional feeding tube formulas to help her father when he was faced with life threatening health issues. The Company offers unique, organic, and whole food alternatives to traditional feeding tube formulas. Liquid Hope and Nourish are nutritionally complete, plant-based, and USDA-certified organic. The Company offers its products to retail customers online and to institutional customers in hospital and long-term care settings.

Duff & Phelps served as exclusive M&A advisor to Functional Formularies in connection with the transaction. 
 
About Functional Formularies
Functional Formularies was founded in 2006 by Robin Gentry McGee who, over the past several decades, has developed a vast knowledge of the food as medicine model. Today, the privately held company serves thousands of customers, hospital formularies, and home health care organizations with Liquid Hope for adults and older children and Nourish for pediatrics, throughout the U.S., Canada, Australia, the U.K. and many other countries.

About Swander Pace Capital
Swander Pace Capital (SPC) is a private equity firm that invests in companies that are integral to consumers' lives. SPC's consumer industry expertise informs the firm's strategic approach and adds value through access to its proven SPC Playbook, senior team, and extensive network. The firm partners with management teams to help build companies to their full potential. SPC invests in businesses across three domains of consumer lifestyles: Food + Beverage, Body + Wellness, and Home + Family. With offices in San Francisco, New Jersey, and Toronto, SPC has invested in more than 50 companies and raised cumulative equity commitments of approximately $1.8 billion since 1996.